Celsius Therapeutics is a startup based in the United States, most recent round Acquired, 1 tracked investor.
Celsius Therapeutics is a company headquartered in the United States. Celsius Therapeutics has been acquired. Brouky records 1 investor associated with the company.
Celsius Therapeutics was a United States–based life sciences/biotechnology company in Catalio Capital's portfolio that focused on developing therapeutic candidates and was exited via M&A in 2024.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.